Speaker Program Limits Are Specific To Novartis Settlement
Law360 (August 17, 2020, 6:09 PM EDT) -- Much has been written about the recent settlement between Novartis Pharmaceuticals Corp. and the U.S. Department of Justice that resolves allegations of misconduct relating to in-person speaker programs held by the company from 2002 to 2011.
In particular, the novel and detailed speaker program restrictions set forth in the associated corporate integrity agreement between Novartis and the U.S. Department of Health and Human Services Office of Inspector General has garnered a great deal of discussion and interest within the pharmaceutical industry, specifically with respect to so-called virtual speaker programs.
The fundamental question many legal and compliance professionals are asking is whether the...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!